Medtronic Millenia high-pressure PTCA balloon catheter offers cost savings through reuse, company says.
This article was originally published in The Gray Sheet
Executive Summary
MEDTRONIC MILLENIA CATHETER APPROVAL gives the firm its first high pressure balloon catheter for percutaneous transluminal coronary angioplasty. Medtronic began sales of the Millenia catheter, which lists at $715, in early October following approval of a premarket application supplement Sept. 25. The PMA supplement to the firm's Omniflex PTCA catheter was filed with FDA in April. The device has been available in Australia, Canada and the European Union since August.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.